CA2664548A1 - Packaging for 1-(2-methylpropyl)-1h-imidazo[4,5-c]quinolin-4-amine-containing formulation - Google Patents
Packaging for 1-(2-methylpropyl)-1h-imidazo[4,5-c]quinolin-4-amine-containing formulation Download PDFInfo
- Publication number
- CA2664548A1 CA2664548A1 CA002664548A CA2664548A CA2664548A1 CA 2664548 A1 CA2664548 A1 CA 2664548A1 CA 002664548 A CA002664548 A CA 002664548A CA 2664548 A CA2664548 A CA 2664548A CA 2664548 A1 CA2664548 A1 CA 2664548A1
- Authority
- CA
- Canada
- Prior art keywords
- packaged composition
- acid
- fatty acid
- formulation
- moisture barrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Abstract
A packaged composition 1-(2-methylpropyl)-1-H-imidazo[4,5-c]quinolin-4-amine dissolved in a fatty acid formulation and contained in a laminated packaging material having a contact layer that includes an acrylonitrile-methyl acrylate copolymer; an outer layer; and a moisture barrier layer disposed between the contact layer and outer layer.
Claims (23)
1. A packaged composition comprising:
a durable laminated packaging material comprising:
a contact layer comprising an acrylonitrile-methyl acrylate copolymer;
an outer layer; and a moisture barrier layer disposed between the contact layer and outer layer;
and a formulation enclosed within the durable laminated packaging material comprising:
a durable laminated packaging material comprising:
a contact layer comprising an acrylonitrile-methyl acrylate copolymer;
an outer layer; and a moisture barrier layer disposed between the contact layer and outer layer;
and a formulation enclosed within the durable laminated packaging material comprising:
2-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine; and a fatty acid.
2. The packaged composition of claim 1 wherein an adhesive is disposed between the contact layer and the moisture barrier layer.
2. The packaged composition of claim 1 wherein an adhesive is disposed between the contact layer and the moisture barrier layer.
3. The packaged composition of claim 1 wherein the outer layer and the moisture barrier layer are bonded together by extrusion bonding with a polymer tie layer.
4. The packaged composition of claim 3, wherein the tie layer is polyethylene.
5. The packaged composition of claim 1 wherein the contact layer is 25 microns to 80 microns thick.
6. The packaged composition of claim 1 wherein the moisture barrier layer is 5 microns to 15 microns thick.
7. The packaged composition of claim 1 wherein the outer layer is 5 millimeters to 20 millimeters thick.
8. The packaged composition of claim 1 wherein the moisture barrier layer comprises a metal foil.
9. The packaged composition of claim 1 wherein the moisture barrier layer comprises aluminum.
10. The packaged composition of claim 1 wherein the outer layer comprises an organic polymer.
11. The packaged composition of claim 1 wherein the outer layer comprises polyethylene terephthalate.
12. The packaged composition of claim 1 wherein the fatty acid is selected from the group consisting of isostearic acid, oleic acid, myristic acid, palmitic acid, palmitoleic acid, margaric acid, stearic acid, linoleic acid, linolenic acid, and mixtures thereof.
13. The packaged composition of claim 12 wherein the fatty acid is isostearic acid, oleic acid, or mixtures thereof.
14. The packaged composition of claim 1 wherein the fatty acid is present in an amount of at least 15% by weight based on the total weight of the formulation.
15. The packaged composition of claim 1 wherein the fatty acid is present in an amount of at least 20% by weight based on the total weight of the formulation.
16. The packaged composition of claim 1 wherein the fatty acid is present in an amount of about 25% by weight based on the total weight of the formulation.
17. The packaged composition of claim 14 wherein the fatty acid is selected from the group consisting of isostearic acid, oleic acid, or mixtures thereof.
18. The packaged composition of claim 17, wherein 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine is present in an amount of 5% by weight of the formulation.
19. The packaged composition of claim 18, wherein the fatty acid is isostearic acid.
20. The packaged composition of claim 18, wherein the fatty acid is oleic acid.
21. The packaged composition of claim 1 wherein the 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine-containing formulation further comprises a preservative.
22. The packaged composition of claim 21 wherein the preservative is selected from the group consisting of methylparaben, propylparaben, benzyl alcohol, and mixtures thereof.
23. The packaged composition of claim 1 wherein the 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine formulation further comprises an emollient, an emulsifier, a thickener, a solubilizing agent, or mixtures thereof.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2006/049518 WO2008082382A1 (en) | 2006-12-29 | 2006-12-29 | Packaging for 1-(2-methylpropyl)-1h-imidazo[4,5-c]quinolin-4-amine containing formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2664548A1 true CA2664548A1 (en) | 2008-07-10 |
| CA2664548C CA2664548C (en) | 2014-04-08 |
Family
ID=39588894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2664548A Expired - Fee Related CA2664548C (en) | 2006-12-29 | 2006-12-29 | Packaging for 1-(2-methylpropyl)-1h-imidazo[4,5-c]quinolin-4-amine-containing formulation |
Country Status (2)
| Country | Link |
|---|---|
| CA (1) | CA2664548C (en) |
| WO (1) | WO2008082382A1 (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4686125A (en) * | 1984-09-28 | 1987-08-11 | Baxter Travenol Laboratories, Inc. | Film laminate for sterile flexible containers |
| US5008110A (en) * | 1988-11-10 | 1991-04-16 | The Procter & Gamble Company | Storage-stable transdermal patch |
| CA2134320C (en) * | 1993-10-26 | 2001-01-09 | Toshiyuki Hirose | Polyolefin multilayer laminate and use thereof |
| AU2002363954B2 (en) * | 2001-11-29 | 2008-04-03 | 3M Innovative Properties Company | Pharmaceutical formulations comprising an immune response modifier |
-
2006
- 2006-12-29 CA CA2664548A patent/CA2664548C/en not_active Expired - Fee Related
- 2006-12-29 WO PCT/US2006/049518 patent/WO2008082382A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008082382A1 (en) | 2008-07-10 |
| CA2664548C (en) | 2014-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0654065B1 (en) | Package material and transdermal drug delivery device | |
| KR101674240B1 (en) | Transdermal Therapeutic System for Administering Rivastigmine or Derivatives thereof | |
| JP6576039B2 (en) | Adhesive patch assembly having an overlay liner and systems and methods for making the same | |
| CA2955241C (en) | Oxymorphone transdermal patch | |
| US8889154B2 (en) | Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation | |
| US6277401B1 (en) | Drug delivery device | |
| JP5933974B2 (en) | Packing bag with patch and preservation method of patch | |
| CA2883128C (en) | Packaging material and packaging structure made by using same | |
| ES2543835T3 (en) | Patch that reduces skin irritation | |
| TWI621448B (en) | Rivastigmine transdermal compositions and methods of using the same | |
| SK10532000A3 (en) | Pharmaceutical composition containing an antioxidant and use of the antioxidant for its stabilisation | |
| KR20050042014A (en) | Plaster having laminated support | |
| KR20140016293A (en) | Transdermal compositions comprising an active agent layer and an active agent conversion layer | |
| DE102007021549A1 (en) | Transdermal therapeutic system containing at least two opioids | |
| EP2711174A1 (en) | Packaging material and package structure using the same | |
| EP2777692A1 (en) | Composition for enhancing transdermal absorption of drug and patch preparation | |
| CA2664548A1 (en) | Packaging for 1-(2-methylpropyl)-1h-imidazo[4,5-c]quinolin-4-amine-containing formulation | |
| JP5883459B2 (en) | Transdermal delivery system containing galantamine or a salt thereof | |
| KR101857316B1 (en) | Patch and patch preparation | |
| US9351942B2 (en) | Patch and patch preparation | |
| JP2009528990A (en) | Adhesive preparation containing sufentanil and method of using the same | |
| CN113423392A (en) | Cooling fin | |
| JP4317075B2 (en) | Patch | |
| JP6872527B2 (en) | Zonisamide-containing transdermal patch | |
| PE20081178A1 (en) | PACKAGING FOR THE FORMULATION CONTAINING 1- (2-METHYLPROPYL) -1H-IMIDAZO [4,5-c] QUINOLIN-4-AMINE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20161229 |